We are delighted to present the Frontiers in Nuclear Medicine 'Women in Radionuclide Therapy: 2023’ article collection.
At present, less than 30% of researchers worldwide are women. Long-standing biases and gender stereotypes are discouraging girls and women away from science-related fields, and STEM research in particular. Science and gender equality are, however, essential to ensure sustainable development as highlighted by UNESCO. In order to change traditional mindsets, gender equality must be promoted, stereotypes defeated, and girls and women should be encouraged to pursue STEM careers.
Therefore, Frontiers in Nuclear Medicine is proud to offer this platform to promote the work of women scientists, across all fields of radionuclide therapy.
The work presented here highlights the diversity of research performed across the entire breadth of radionuclide therapy research and presents advances in theory, experiment, and methodology with applications to compelling problems. In addition, we also welcome historical reviews of the advances of women in this field, Marie Curie being a notable example.
Please note: to be considered for this collection, the first or last author should be a researcher who identifies as a woman.
We are delighted to present the Frontiers in Nuclear Medicine 'Women in Radionuclide Therapy: 2023’ article collection.
At present, less than 30% of researchers worldwide are women. Long-standing biases and gender stereotypes are discouraging girls and women away from science-related fields, and STEM research in particular. Science and gender equality are, however, essential to ensure sustainable development as highlighted by UNESCO. In order to change traditional mindsets, gender equality must be promoted, stereotypes defeated, and girls and women should be encouraged to pursue STEM careers.
Therefore, Frontiers in Nuclear Medicine is proud to offer this platform to promote the work of women scientists, across all fields of radionuclide therapy.
The work presented here highlights the diversity of research performed across the entire breadth of radionuclide therapy research and presents advances in theory, experiment, and methodology with applications to compelling problems. In addition, we also welcome historical reviews of the advances of women in this field, Marie Curie being a notable example.
Please note: to be considered for this collection, the first or last author should be a researcher who identifies as a woman.